The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₩16,064.49Fair value₩40,122.03Bull₩70,299.31
FairClose
52-week traded range
52W low ₩46,200.0052W high ₩70,800.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
InBody Co., Ltd. closed at ₩57,600.00, 43.6% above the consensus fair value of ₩40,122.03 drawn from 10 valuation models.
Financial DNA score 54/100 — Good. P/E of 23.8x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₩40,403.55
-29.9%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=6.6%, r=10%, tg=3%, n=10yr
Graham Number
₩36,022.31
-37.5%
√(22.5 × EPS × BVPS)
EPS=2423, BVPS=23801.65 · outside Graham range (P/E 23.8, P/B 2.4) — asset-light, treat as a rough floor
Graham Formula
₩70,299.31
+22.0%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=6.6%, FD=3.3%
P/E Fair Value
₩48,460.00
-15.9%
EPS × 20x (sector P/E)
EPS=2423, Sector P/E=20x
Peter Lynch (PEG)
₩16,064.49
-72.1%
EPS × Growth% (PEG = 1 is fair)
EPS=2423, g=6.6%
EV/EBITDA
₩39,495.28
-31.4%
(EBITDA × 13.3x − Net Debt) ÷ Shares
EBITDA=36.75B
Dividend Discount (DDM)
₩31,347.32
-45.6%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=990.72, r=10%, g=6.6%
Book Value (P/B)
₩21,659.50
-62.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=23801.65, ROE=9.6%, g=6%, r=10%
Reverse DCF
₩57,600.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 9.5% | Historical: 6.6%
Margin of Safety
₩36,597.22
-36.5%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=48796.29, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.